Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 17.0B | 14.5B | 17.6B | 15.0B |
Cost of revenue | 7.0B | 6.5B | 7.1B | 6.5B |
Gross profit | 10.0B | 8.0B | 10.4B | 8.4B |
Operating expense | ||||
Research & development | 2.1B | 2.0B | 2.0B | 1.9B |
Selling general and admin | 4.7B | 4.3B | 4.6B | 4.3B |
Other operating expenses | -215M | -253M | -301M | -238M |
Operating income | 3.1B | 1.8B | 3.9B | 2.2B |
Non operating interest income | ||||
Income | 172M | 191M | 150M | 170M |
Expense | 510M | 455M | 424M | 429M |
Other income expense | -151M | -343M | -320M | -2.7B |
Pretax income | 2.6B | 1.2B | 3.3B | -802M |
Tax provision | 404M | 103M | 379M | -485M |
Net income | 2.2B | 1.1B | 2.9B | -330M |
Basic EPS | 2.4 | 1.1 | 3.2 | -0.4 |
Diluted EPS | 2.3 | 1.1 | 3.1 | -0.4 |
Basic average shares | 930.8M | 928M | 926M | 923.6M |
Diluted average shares | 948.0M | 945.4M | 942.4M | 923.6M |
EBITDA | 4.5B | 3.1B | 4.2B | 1.2B |
Net income from continuing op. | 2.2B | 1.1B | 2.9B | -330M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |